Task: Answer Verification
Input (English): Question: Does addition of aprepitant improve protection against cisplatin-induced emesis when a conventional anti-emetic regimen fails?
Answer: In patients with lung cancer receiving cisplatin-based chemotherapy, the addition of aprepitant to a 5-HT3 antagonist, dexamethasone, and metoclopramide improves protection against CINV when the conventional anti-emetic regimen fails.
Output (English): yes